Dr. Jansen´s scientific background is based on a Ph.D. in biochemistry/molecular medicine from Harvard Medical School and the University of Bremen.

He has over 20 years of experience in the Healthcare industry with different C-Level positions in international strategic consultancies like Booz Allen Hamilton/booz&co. in Dubai and global healthcare companies like GE Healthcare in Paris and Chicago as well as CSC/DXC Technology in Germany.

Until April 2022, he had first been CEO and then Executive Board Member of the Munich-based NOVENTI Group. Within the NOVENTI Group, his responsibilities focused on new business innovation, consumer & retail health, health data analytics, digital transformation and sustainability.

From mid 2022 he embodied the position of CEO of INNO3 in Leipzig, Germany before joining Neo Q in April of 2023. Dr. Jansen is an author, keynote-speaker and recipient of the LSC Leadership award of the Vatican.

His commitment for planetary health & sustainability is internationally recognized. Due to his scientific and professional career, his industry emphasis include payer, provider, public funds as well as life sciences, pharma, biotech/biosimilars
and MedTech.